| | Indication | | Albumin dose (gm) | Duration (d) | Desired outcome |
| | LVP | 50 | 55.0 ± 13.4 | 1 | 46/50 (92%) | | SBP | 6 | 162.5 ± 89.1 | 2.8 ± 1.5 | 6/6 (100%) | | HRS | 9 | 436.1 ± 310.5 | 8.9 ± 6.0 | 3/9 (33%) | | Non-HRS AKI | 15 | 215.0 ± 184.6 | 3.9 ± 2.1 | 11/15 (73%) | | Ascites mobilization | 5 | 205.0 ± 144.0 | 4.0 ± 3.0 | 0/5 (0%) | | Hyponatremia | 5 | 205.0 ± 118.0 | 4.4 ± 2.3 | 4/5 (80%) | | Hypotension | 2 | 100, 25 | 2, 1 | 0/2 (0%) | | Hypoalbuminemia | 3 | 50, 150, 75 | 1, 3, 1 | 1/3 (33%) | | Edema | 2 | 50, 50 | 2, 1 | 1/2 (50%) | | Hypovolemia | 3 | 25, 50, 200 | 1, 1, 4 | 1/3 (33%) |
|
|
